Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel…

By L. Bonello, L. Camoin-Jau, S. Arques, C. Boyer, Dimitri Panagides, O. Wittenberg, M. Siméoni, P. Barragan, F. Dignat-George, F. Paganelli. Journal of the American College of Cardiology, 2008

605 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Oncology

View Paper: https://www.semanticscholar.org/paper/a361009f21c2d459b7b1014360792bcb114ce663

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

L. Bonello
U. Tantry
V. Ferraris
Gregg Stone
N. Breet
Deepak L. Bhatt
M. Price
R. Marcucci

Citations in the corpus

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. (2010, result): “However, the individual response to dual antiplatelet therapy is not uniform, and consistent findings across multiple investigations support the association between a lower degree of platelet inhibition, a high on-treatment platelet reactivity, and the occurrence of atherothrombotic events.(3-10) Th”
2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. (2011, background): “More accurate tests are available but are not point-of-care tests [32, 35].”
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. (2013, background): “This strategy was associated with significantly reduced subsequent adverse event occurrence, including early ST without increasing bleeding (38,39).”
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. (2010, background): “Recent studies (62,64,72,76,77) have observed the rognostic value of the VASP phosphorylation analysis, r ith an optimal cutoff value for VASP-PRI between 48% nd 53%, which is similar to the threshold defined by arragan et al.”
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI: A Meta-Analysis (2010, neutral): “highlighted the predictive value of platelet function testing.(53) In conclusion, the findings of this”